London-based BenevolentAI, which uses drug industry data and research to discover new drug purposes, highlights the promise of AI in fight against COVID-19 (Tom Simonite/Wired)

[ad_1]

Tom Simonite / Wired:

London-based BenevolentAI, which uses drug industry data and research to discover new drug purposes, highlights the promise of AI in fight against COVID-19  —  Software urged an arthritis drug may quell an out-of-control immune response that damages the lungs.  Now it is being examined in a medical trial.